Updated on 21 February 2017
Clinical Diabetes offers long feature articles, which can present either original research or reviews of a given topic in clinical diabetes care. The journal also includes several standing departments, which offer shorter articles focused on well-defined topic areas. Guidelines for each type of article are included in separate sections below.
Feature articles on topics related to diabetes in primary practice are published in each issue of Clinical Diabetes. If the article is invited, a member of the editorial team will discuss content with invited author at the time the invitation is extended. Unsolicited manuscripts are also welcome to be submitted for consideration.
Each feature article should be approximately 3000-6000 words long, including references. The word count for articles that contain tables, figures, or other illustrations should be adjusted down by approximately 500 words for every half-page table, figure, or illustration. (Example: if an author is planning to include two half-page tables, the total word count on the article text (not counting the tables) should be 2000-5000 to ensure enough room for the tables.)
Feature articles should follow the guidelines for manuscript format, style, and submission requirements set forth below. Authors should include a very short (2-3 sentence) “In Brief” summary of the article, which will appear on the first page of the printed article in lieu of a traditional abstract. Examples of feature articles can be found in issues on the journal website.
Articles written for the "Case Studies" department present real patient cases from the authors' practices illustrating specific points in the care of diabetes patients. Each article should be approximately 800-1600 words and should follow the guidelines for manuscript format, style, and submission requirements set forth below. "Case Studies" articles should be structured in the following format:
- Case study title
- Your name
- Brief case presentation, including symptoms at presentation, significant history, physical exam, and lab results
- Questions raised by this case
- Summary of the "clinical pearls" exemplified by this case
- A brief list of references or suggested readings
Clinical Pharmacology Update
Articles in “Clinical Pharmacology Update” are invited articles (no unsolicited submissions considered) summarizing pharmaceutical agents for the treatment of diabetes. Articles should be 500–1,000 words in length with less than 10 references. These articles follow a specific template, as follows:
- Indications (label and off-label)
- Mechanism of action
- Potential advantages
- Potential disadvantages
- Cost (using some standard metric or website (1 month of a middle-range dose)
- Comments: Discussion of studies key to the disease being treated with emphasis on the diabetes population
- Bottom line: The clinical implications for diabetes treatment
Commentaries should be opinion articles of approximately 800 words in length. The articles should follow the guidelines for manuscript format, style, and submission requirements set forth below. Examples of each department can be found in issues on the journal website.
Articles for “Diabetes Advocacy” are written or invited by American Diabetes Association or Clinical Diabetes staff (no unsolicited submissions considered) and focus on the Association’s advocacy efforts on behalf of people with diabetes.
Editorials are short (approximately 800 words) commentaries written or invited by the journal’s Editor-in-Chief. The articles should follow the guidelines for manuscript format, style, and submission requirements set forth below. Examples of each department can be found in issues on the journal website.
Letter to the Editor
Letters should be brief (≤800 words) and should comment specifically on an article that has been published in the journal. Authors should provide a citation for the article on which they are commenting.
Articles in the "Practical Pointers" department offer a discussion of the basics of some aspect of diabetes care. These articles should be approximately 2400-4000 words long and should follow the guidelines for manuscript format, style, and submission requirements set forth below.
Quality Improvement Success Stories
This series, published in collaboration with the American College of Physicians and the National Diabetes Education Program, highlights best practices and strategies from programs and clinics that have successfully improved the quality of care for people with diabetes. Diabetes health care professionals who wish to share information about their quality improvement initiatives are encouraged to do so by completing a template and submitting it through the journal’s online submission system. All submissions will be reviewed by the journal’s editorial team. All accepted articles will be published online; selected articles will also be published in print.
Translating Research to Practice
Articles written for the "Translating Research to Practice" department offer summaries and discussions of current research studies related to diabetes clinical care. Each article should be approximately 1600 words long and should follow the guidelines for manuscript format, style, and submission requirements set forth below. "Translating Research to Practice" articles should be structured in the following format:
- Title of your article
- Citation for the research study on which you are writing, including all author names, full title of the research article, journal of publication, volume, page range, and year of publication
- Reviewed by (your name)
- Summary of the research article, including brief descriptions of the study objective, design, subjects, methods, results, and conclusion
- Discussion of the significance of this research, including its applicability to clinical diabetes care, especially in the primary practice setting
All text and tables should be saved in Word document format. Doing so will allow our Editorial Office to verify the word count and our production staff to turn your paper (if accepted) into an article. Please do not use headers, footers, or endnotes in your paper.
Every manuscript must have an accompanying title page. The title page should include the title; the first name, middle initial, last name, and the highest academic degree of each author; affiliation (in English) of each author; and name, current address, telephone number, fax number, and e-mail address of the corresponding author.
The acknowledgments should go after the main text and before the reference list. Acknowledgments should contain brief statements of assistance, financial support, and prior publication of the study in abstract form, where applicable.
The reference list should go at the end of the document, after the main text and acknowledgments (if applicable) and before the tables. References should be numbered in the order that they are cited in the text.
Reference numbers in the text should be in normal type and in parentheses [e.g., "In the study by Norton et al. (23)..."]. Please do not use the footnote/endnote functions found in some word processing programs.
See below for examples of how to style each reference in the reference list.
Tables should be double spaced on separate pages and included at the end of the text document, with the table number and title indicated. Tables should be created using Word and the "Insert Table" command; please do not use tabs or spaces to create tables, columns, or rows. Tables with internal divisions (Tables 1A and B) should be submitted as individual tables, i.e., Tables 1 and 2. Symbols for units should be confined to column headings. Abbreviations should be kept to a minimum and defined in the table legend. For footnotes, use the following symbols consecutively, left to right, top to bottom of table: *, †, ‡, §, ||, ¶, #, **, ††, etc.
If tables are taken from other sources, the author must be able to provide written permission for reproduction obtained from the original publisher and author.
Clinical Diabetes uses digital publishing methods throughout the journal production process. If your article is accepted, it will be published both in the printed journal and online. The following sections provide information on how to format your figures to ensure the best possible reproduction of your images.
Size. Figures should be produced at the size they are to appear in the printed journal. Please make sure your figures will fit in one, two, or three columns in width. Multi-paneled figures should be assembled in a layout that leaves the least amount of blank space.
1 column = 13 picas wide, 2.2 in, 5.6 cm
2 columns = 28 picas wide, 4.6 in, 11.7 cm
3 columns = 41 picas, 6.8 in, 17.3 cm
Font. At 100% size, fonts should be 8-10 points and used consistently throughout all figures.
Text. Information on the axes should be succinct, using abbreviations where possible, and the label on the y-axis should read vertically, not horizontally. Key information should be placed in any available white space within the figure; if space is not available, the information should be placed in the legend. In general, figures with multiple parts should be marked A, B, C, etc., with a description of each panel included in the legend rather than on the figure.
Line and bar graphs. Lines in graphs should be bold enough to be easily read after reduction, as should all symbols used in the figure. Data points are best marked with the following symbols, again assuring that they will be readily distinguishable after reduction: In the figure legend, please use words rather than the symbols; e.g., "black circles = group 1; white squares = group 2; black bars = blood glucose; white bars = C-peptide." Bars should be black or white only, unless more than two datasets are being presented; additional bars should be drawn with clear bold hatch marks or stripes, not shades of gray. Line or bar graphs or flow charts with text should be created in black and white, not shades of gray, which are difficult to reproduce in even tones.
Reproductions. If materials (e.g., figures and/or tables) are taken from other sources, the author must be able to provide written permission for reproduction obtained from the original publisher and author. In addition, the source should be cited at the end of the figure legend.
Figure legends. Figure legends should be clearly numbered and included at the very end of your main text document and should not be included on the separate figure/image files. Please use words to describe symbols used in the figure; e.g., "black circles = group 1; white squares = group 2; black bars = blood glucose; white bars = C-peptide."
Formatting digital files for print reproduction. To meet ADA’s quality standards for publication, it is important to submit digital art that conforms to the appropriate resolution, size, color mode, and file format. Doing so will help to avoid delays in publication and maximize the quality of images, both online and in print. Please refer to ADA's Digital Art Guidelines when preparing your files. If you are unable to provide files that meet the specifications outlined in the Guidelines, you may submit your original source files (files from the program in which they were originally created).
Electronic submission of illustrations is encouraged; however, laser-printed, camera-ready artwork may be necessary if submitted electronic files fail to meet criteria for print publishing. Hard-copy versions of figures for accepted manuscripts should be computer-generated laser prints on high-quality laser printer paper. Authors may be asked to prepare new figures if those submitted are not suitable for reproduction. Each figure must have a legend that appears in the text and not on the figure.
Terminology and Style
Articles should be written in clear, concise English following the recommendations for scientific writing found in Scientific Style and Format, the Council of Biology Editors (CBE) style manual (6th ed., 1994, Bethesda, MD, Council of Biology Editors). All accepted manuscripts will be edited according to the CBE style manual and The Chicago Manual of Style (15th ed., 2003, Chicago, IL, The University of Chicago Press) by ADA professional publications staff. The authors are responsible for all statements made in their articles or editorials, including any editing changes made by staff.
The designations type 1 diabetes and type 2 diabetes should be used when referring to the two major forms of diabetes. Abbreviations for diabetes, such as T2D for type 2 diabetes, should not be used. The term diabetic should not be used as a noun. Pharmaceutical agents should be listed by generic name.
Abbreviations should be used only when necessary, e.g., for long chemical names (HEPES), procedures (ELISA), or terms used throughout the article. Abbreviate units of measure only when used with numbers. Abbreviations may be used in tables and figures. The CBE style manual contains lists of standard scientific abbreviations.
Clinical laboratory values should be in Système International (SI) form. Kilocalories should be used rather than kilojoules. Glycated hemoglobin should be expressed as percentage of total and as standard deviation from mean control levels.
References should be listed according to the following examples and should be numbered in the order that they are cited in the text. All authors must be listed and inclusive page numbers provided. Journal titles should be abbreviated as in the National Library of Medicine's List of Journals Indexed for Medline; for unlisted journals, complete journal titles should be provided. Material that is in press may be cited, but copies of such material may be requested. Authors are responsible for the accuracy of the references.
Banting FG, Best C: The internal secretion of the pancreas. J Lab Clin Med 7:251-266, 1922
Seaborn J: Gastrointestinal side-effects of high-fiber diets in diabetic rats (Abstract). Gut 33:A4304, 1992
Allen FM: Studies Concerning Glycosuria and Diabetes. Bradley RF, Krall LP, Eds. Cambridge, MA, Harvard Univ. Press, 1913
Chapters in books:
Stauffacher W, Renold AK: Pathophysiology of diabetes mellitus. In Joslin's Diabetes Mellitus. 11th ed. Marble A, White P, Bradley RF, Krall LP, Eds. Philadelphia, Lea & Febiger, 1971, p. 35-98
Fajans SS (Ed.): Diabetes Mellitus. Washington, DC, U.S. Govt. Printing Office, 1976 (DHEW publ. no. NIH 76-854)
Proceedings and symposia:
Steel JM: Prepregnancy counseling and the management of the pregnant woman with diabetes. In Proceedings of the 39th Annual Advanced Postgraduate Course, Orlando, FL, 1992. Alexandria, VA, American Diabetes Association, p. 97-98
Beta cell function in type 2 diabetes: glucose metabolism and insulin secretion in the normal pancreas [article online], 1999. Available from http://www.amaryl.com/TXT/Clinical_Management/Overview/beta_cell_failure_TXT.html. Accessed 4 May 2000
The American Diabetes Association (ADA) holds the copyright on all material appearing in Clinical Diabetes. All authors must check the appropriate boxes and sign the manuscript submission form, which transfers copyright to the ADA in accordance with the Copyright Revision Act of 1976.
Duality of Interest
All authors must sign, check the appropriate box(s) on, and submit a manuscript submission form (available on the website). Any author who has a duality of interest to disclose must attach an additional statement that explains the nature of the duality or conflict of interest. Relevant duality or conflict of interest (or lack thereof) should also be disclosed in the authors' comments to the editor during the submission process.
Accepted manuscripts will be scheduled for publication as soon as possible. Correspondence concerning the copyediting and production of accepted manuscripts should be e-mailed to Debbie Kendall, Managing Editor, Clinical Diabetes, at email@example.com or firstname.lastname@example.org.
Once an article is submitted, it will be substantively reviewed by the editorial team. A member of the editorial team will contact you if substantive revisions are necessary. Otherwise, your paper will then be forwarded to Clinical Diabetes staff for copyediting for style, grammar, and clarity. The copyedited article will be faxed to you with any final author queries for your final revision and/or approval of the manuscript. Typesetting and page design occur after your final approval. Authors do not review galley proofs.
Reuse, Post-Prints, and Public Access
Reuse. Authors are permitted to reuse portions of their ADA-copyrighted work, including tables and figures, in their own work, and to reuse portions or all of their ADA-copyrighted work for educational purposes, without submitting a request to ADA, provided that the proper citation and copyright information is given.
Post-prints. Authors are permitted to submit the final, accepted version of their manuscript to their funding body or institution for inclusion in their funding body or institution's database, archive, or repository, or to post the final, accepted version on their personal website. These manuscripts may be made freely accessible to the public upon acceptance provided certain conditions are observed. See the Policies and Procedures tab of the journal’s website for more details.
Public access. As a courtesy to authors, the final print versions of articles will be deposited in PubMed Central (PMC). In compliance with National Institutes of Health policy, these articles will appear on PMC 12 months after print publication in Clinical Diabetes and will be indexed on PubMed/Medline.
Full-text HTML content is freely accessible 6 months after the print publication date, and PDF content is freely accessible 12 months after the print publication date.